Biochemical and pharmacological studies of bovine liver hydrolysate / Монголын Анагаах Ухаан

ABSTRACT

BackgroundPreliminary clinical studies indicate that liver extract may be helpful in treating hepatic dysfunction. In addition, liver extract seems to work synergistically with interferon in treating hepatitis C and other viral infections. Laboratory studies indicate that liver extract may have some effects that could be useful in treating certain forms of cancer, such as ability to direct migration of metastasizing cells and inhibition of DNA, RNA and protein formation. More research is needed in these areas to determine liver hydrolysate’s properties.Materials and MethodsSeveral biochemical methods were used for determination of chemical compounds in liver extracts Total protein and nitrogen content was determined by Kjeldahl method; mineral contents – atomic absorption spectrophotometer; Heme iron content – spectrophotometer; Water soluble vitamins - HPLC method. The pharmacological activities of bovine liver were tested by several pharmacological methods: Acute toxicity – LD50 /Prozorovskii 1978/; Acute hepatitis – Carbon tetrachloride (CCl4) induced liver damage in rats /Skakun et al, 1984/; Biochemical parameters in blood serum – Automatic biochemical analyzer.ResultThe values obtained in determination of the biochemical analysis show that 100 g consumption of studied liver hydrolysate can provide 4.3, 2.1 and 0.3 mg vitamin B1, B3 and B9 respectively. Therefore, present data reveal that liver hydrolysate is a good source of most of the analyzed minerals. The liver hydrolysate contains 56.4% total protein and 4.33% amino nutrient.Conclusions:1. From the results of pharmacological study that involves CCl4 induced acute toxic hepatitis, liver hydrolysate has hepatoprotective effect by protecting the liver cells from injury, improving the regeneration process and by correcting metabolic functions of the liver.2. When tested, hydrolysate’s pharmacological parameters can be analyzed reliably with several liver damage experimental designs, further improvements or the use of new designs such as anemia is needed in further pharmacological study.